Literature DB >> 23811125

New perspectives in nanomedicine.

Andrew J Thorley1, Teresa D Tetley.   

Abstract

Recent advances in nanotechnology have revolutionised all aspects of life, from engineering to cosmetics. One of the most exciting areas of development is that of nanomedicine. Due to their size (less than 100nm in one aspect), nanoparticles exhibit properties that are unlike that of the same material in bulk size. These unique properties are being exploited to create new diagnostics and therapeutics for application in a broad spectrum of organ systems. Indeed, nanoparticles are already being developed as effective carriers of drugs to target regions of the body that were previously hard to access using traditional drug formulation methods. However, in addition to their role as a vehicle for drug delivery, nanoparticles themselves have the potential to have therapeutic benefit. Through manipulation of their elemental composition, size, shape, charge and surface modification or functionalisation it may be possible to target particles to specific organs where they may elicit their therapeutic effect. In this review we will focus on the recent advances in nanotechnology for therapeutic applications with a particular focus on the respiratory system, cancer and vaccinations. In addition we will also address developments in the field of nanotoxicology and the need for concomitant studies in to the toxicity of emerging nanotechnologies. It is possible that the very properties that make nanoparticles a desirable technology for therapeutic intervention may also lead to adverse health effects. It is thus important to determine, and appreciate, the fine balance between the efficacy and toxicity of nanomedicine.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATI; ATII; Alveolar type I epithelial; Alveolar type II epithelial; CNT; COPD; Cancer; Carbon nanotube; Carbon nanotubes; Chronic Obstructive Pulmonary Disease; EGF; Epidermal growth factor; Lung; Nanoparticles; Nanotoxicology; PCL; PEG; Periciliary liquid; Polyethylene glycol; RSV; Respiratory syncytial virus; Silver; TB; TT1; Transformed Type I; Tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 23811125     DOI: 10.1016/j.pharmthera.2013.06.008

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  33 in total

Review 1.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

Review 2.  The evolving landscape of drug products containing nanomaterials in the United States.

Authors:  Sheetal R D'Mello; Celia N Cruz; Mei-Ling Chen; Mamta Kapoor; Sau L Lee; Katherine M Tyner
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

Review 3.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors:  Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

4.  Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexes.

Authors:  Yun Wu; Junyu Ma; Parker S Woods; Nicholas M Chesarino; Chang Liu; L James Lee; Serge P Nana-Sinkam; Ian C Davis
Journal:  J Control Release       Date:  2015-02-14       Impact factor: 9.776

5.  Calligonum comosum and Fusarium sp. extracts as bio-mediator in silver nanoparticles formation: characterization, antioxidant and antibacterial capability.

Authors:  Afrah E Mohammed; Fadwa F Bin Baz; Jehan S Albrahim
Journal:  3 Biotech       Date:  2018-01-13       Impact factor: 2.406

6.  Combinatorial Use of Therapeutic ELP-Based Micelle Particles in Tissue Engineering.

Authors:  Beyza Bulutoglu; Aylin Acun; Sarah L Deng; Safak Mert; Elise Lupon; Alexandre G Lellouch; Curtis L Cetrulo; Basak E Uygun; Martin L Yarmush
Journal:  Adv Healthc Mater       Date:  2022-04-28       Impact factor: 11.092

Review 7.  Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection.

Authors:  Valentina Ruggiero; Rita P Aquino; Pasquale Del Gaudio; Pietro Campiglia; Paola Russo
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

Review 8.  Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.

Authors:  Caleb F Anderson; Maria E Grimmett; Christopher J Domalewski; Honggang Cui
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-10

9.  Static and Dynamic Microscopy of the Chemical Stability and Aggregation State of Silver Nanowires in Components of Murine Pulmonary Surfactant.

Authors:  Ioannis G Theodorou; Danielle Botelho; Stephan Schwander; Junfeng Zhang; Kian Fan Chung; Teresa D Tetley; Milo S P Shaffer; Andrew Gow; Mary P Ryan; Alexandra E Porter
Journal:  Environ Sci Technol       Date:  2015-06-25       Impact factor: 9.028

10.  Aerosol droplet delivery of mesoporous silica nanoparticles: A strategy for respiratory-based therapeutics.

Authors:  Xueting Li; Min Xue; Otto G Raabe; Holly L Aaron; Ellen A Eisen; James E Evans; Fred A Hayes; Sumire Inaga; Abderrahmane Tagmount; Minoru Takeuchi; Chris Vulpe; Jeffrey I Zink; Subhash H Risbud; Kent E Pinkerton
Journal:  Nanomedicine       Date:  2015-03-25       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.